- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02022553
Procedure RACHEL in Complex Treatment of Rectal Cancer (RACHEL)
Complex Treatment of Rectal Cancer
AIM OF RESEARCH. The aim of our research is to improve the results of the combined treatment of patients with locally advanced rectal cancer using endovascular methods and reservoir and plastic surgery.
TASKS OF RESEARCH.
- To assess the immediate and long-term results of combined (chemoradiation and surgical) treatment for locally advanced rectal cancer.
- To make a comparative evaluation of the results of independent surgical and combined (chemoradiation and surgery) treatment of patients with locally advanced rectal cancer.
- To examine functional results of surgical treatment with the formation of "neosphincter" and "neorectum" in patients with colorectal cancer..
- To study features of blood supply to the rectum from the pools of the inferior mesenteric and internal iliac arteries, using the method of selective angiography, in connection with the development of endovascular treatment of rectal cancer.
- To develop and introduce into clinical practice method of one-stage selective intra-arterial oil chemoembolization of upper, middle and lower rectal arteries in patients with locally advanced rectal cancer, who have a contraindication to preoperative radiotherapy.
- To assess the immediate and long-term results of combined (endovascular and surgical) treatment for locally advanced rectal cancer.
- To optimize tactics of combined treatment of locally advanced rectal cancer by developing an algorithm of using chemoradiotherapy and endovascular interventions in the preoperative period.
NOVELTY OF RESEARCH.
- As a result of research will be designed and implemented a new method of selective intra-arterial chemoembolization in rectal arteries preoperatively in patients with locally advanced rectal cancer.
- Substantiated high effectiveness of the proposed technique for the removal of colonic obstruction and, as a consequence perform radical surgical treatment of these patients.
- First developed dosage and concentration of chemotherapeutic agent and embolic agent for safe injection when performing selective intra-arterial chemoembolization of rectal arteries.
- Developed complex techniques of selective intra-arterial chemoembolization of rectal arteries preoperatively in patients with locally advanced rectal cancer.
- Will be made a comparative analysis of the postoperative period and the evaluation of the quality of life of operated patients Obtained data will be presented for use in clinical practice. POSSIBLE APPLICATION AREAS. Results of the research designed for use in the treatment process of departments of Coloproctology, oncology, as well as the educational process of higher and secondary medical institutions.
EXPECTED EFFECTIVENESS.
It is expected that the use of this method of treatment of patients with locally advanced rectal cancer in clinical practice will provide pronounced effect:
- Medical and social - improving the quality of care, preservation of social activity of patients, reducing mortality;
- Economic - reducing the time of patients' treatment and reducing the number of therapeutic manipulation;
- Science and Technology - improving of the training level of medicine workers in the treatment of patients with rectal cancer.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Voronezh Region
-
Voronezh, Voronezh Region, Russian Federation, 394066
- Voronezh Regional Hospital #1
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Clinical diagnosis of rectal cancer T3-4N0-2M0
- complication of bowel obstruction
- No allergy on contrast agent
- Previously not operated about rectal cancer
- Not older than 75 years
Exclusion Criteria:
- Older 75 years
- Previously operated about rectal cancer
- Allergy to contrast agent
- No bowel obstruction
- No rectal cancer
- No locally advanced rectal cancer
- Clinical diagnosis of rectal cancer Tis-4N0-2M1 (generalized rectal cancer)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: rectal cancer, surgery
|
|
|
Active Comparator: rectal cancer, RACHEL, surgery
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
tumor reduction
Time Frame: 5-10 days
|
5-10 days
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NNKOR2013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rectal Cancer T3-4N0-2M0
-
Institut Cancerologie de l'OuestMerck Sharp & Dohme LLCTerminatedRectal Cancer | Stage II/III | T3 or T4 (Only Anal Extension) Rectal Cancer | N0-2 | M0France
-
Memorial Sloan Kettering Cancer CenterTesaro, Inc.RecruitingSolid Tumor | Solid Tumor, Adult | Rectal Adenocarcinoma | Clinical Stage: Stage II (T3-4, N-) | Stage III (Any T, N+)United States
-
Yantai Yuhuangding HospitalSichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Not yet recruitingNeoadjuvant Therapy | Stage II to III (T1cN1-2 or T2-4N0-2) TNBC Breast CancerChina
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedStage T3-4NxM0 Gastric CancerSingapore
-
The Second Hospital of Shandong UniversityShandong Cancer Hospital and Institute; Wuhan YZY Medical Science and Technology...UnknownEsophageal Cancer TNM Staging Primary Tumor (T) T3China
-
Ohio State University Comprehensive Cancer CenterNovartis Pharmaceuticals; National Comprehensive Cancer NetworkCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Recurrent Rectal CancerUnited States
-
First Affiliated Hospital of Wenzhou Medical UniversityCompletedRectal Cancer Stage | Rectal Cancer PatientsChina
-
M.D. Anderson Cancer CenterRecruitingEvaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal CancerStage III Rectal Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Stage IV Rectal Cancer AJCC v8 | Stage IVA Rectal Cancer AJCC v8 | Stage IVB Rectal Cancer AJCC v8 | Stage IVC Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage... and other conditionsUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)WithdrawnStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Rectal AdenocarcinomaUnited States
-
Jonsson Comprehensive Cancer CenterNatera, Inc.; The Joseph Drown FoundationRecruitingStage III Rectal Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage IIA Rectal Cancer AJCC v8 | Stage IIB Rectal Cancer AJCC v8 | Stage II Rectal Cancer AJCC v8 | Stage IIC Rectal Cancer AJCC v8 | Locally...United States
Clinical Trials on usual rectal cancer surgery
-
Dr. Lutfi Kirdar Kartal Training and Research HospitalCompleted
-
Binh Dan HospitalCompleted
-
Countess of Chester NHS Foundation TrustUnknownRectal CancerUnited Kingdom
-
University of California, IrvineUniversity of LeedsCompleted
-
Oxford University Hospitals NHS TrustUniversity of Leeds; Endomagnetics Ltd.Terminated
-
Consorci Sanitari de TerrassaRecruiting
-
Hospital Universitario Virgen de la ArrixacaCompleted
-
Université de SherbrookeCompletedSexual Dysfunction | Patient Satisfaction | Rectal Surgery
-
University of Rome Tor VergataCompletedRectal Cancer | Anastomotic Leak Rectum
-
Taiyuan LiCompletedRectal Neoplasms | Robotic Surgery | Natural Orifice Specimen Extraction Surgery